Related Experiment Video
Updated: Jul 14, 2026

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
Published on: January 19, 2024
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin
Jiri Trcka1, Cornelia S Seitz, Eva-B Bröcker
1Department of Dermatology, Venerology and Allergology, University of Würzburg, Würzburg, Germany.
Objectives:
Aminopenicillin-induced exanthema poses a problem in the management of infectious diseases. Due to theoretically possible immunological cross-reactivity, all beta-lactam drugs, i.e. penicillins, penicillin derivatives and cephalosporins, are usually avoided. The available alternative antibiotics (macrolides, quinolones and glycopeptides) may be less effective, have more side effects, and their use increases medical costs. Moreover, their use contributes to the increasing bacterial resistance to antibiotics. The aim of the study is to demonstrate that patients with aminopenicillin-induced exanthema may receive specific beta-lactams for future antibiotic therapy.
Methods:
Skin testing followed by oral challenges to identify beta-lactams that are tolerated by patients despite confirmed delayed-type non-immunoglobulin E (IgE)-mediated allergic hypersensitivity to aminopenicillins.
Results:
Sixty-nine out of 71 patients (97.2%) with non-IgE-mediated allergic hypersensitivity to aminopenicillins tolerate cephalosporins without an aminobenzyl side chain such as cefpodoxime or cefixime and 51 patients (71.8%) also tolerate phenoxymethyl penicillin.
Conclusions:
The majority of patients with non-IgE-mediated allergic hypersensitivity to aminopenicillins do not cross-react to certain cephalosporins or phenoxymethyl penicillin. Skin and drug challenge tests can be helpful to determine individual cross-reactivity.
Insights
Patients with aminopenicillin-induced exanthema can often tolerate specific cephalosporins or phenoxymethyl penicillin. Allergy testing helps identify safe beta-lactam antibiotics, avoiding less effective alternatives and antibiotic resistance.
Area of Science:
- Infectious Diseases
- Clinical Immunology
- Pharmacology
Background:
- Aminopenicillin-induced exanthema complicates infectious disease management.
- Cross-reactivity concerns often lead to avoidance of all beta-lactams.
- Alternative antibiotics may be less effective and contribute to resistance.
Purpose of the Study:
- To demonstrate that patients with aminopenicillin-induced exanthema can safely receive specific beta-lactams.
- To evaluate the potential for cross-reactivity between aminopenicillins and other beta-lactams.
- To provide evidence for personalized antibiotic selection in allergic patients.
Main Methods:
- Skin testing followed by oral challenges.
- Identification of tolerated beta-lactams in patients with confirmed hypersensitivity.
- Focus on non-immunoglobulin E (IgE)-mediated reactions.
Main Results:
- 97.2% of patients tolerated cephalosporins lacking an aminobenzyl side chain (e.g., cefpodoxime, cefixime).
- 71.8% of patients tolerated phenoxymethyl penicillin.
- High tolerance rates suggest limited cross-reactivity in this patient group.
Conclusions:
- Most patients with non-IgE-mediated hypersensitivity to aminopenicillins tolerate certain cephalosporins and phenoxymethyl penicillin.
- Skin and drug challenge tests are valuable for assessing individual cross-reactivity.
- This approach can guide safer antibiotic selection and reduce reliance on alternative agents.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Allergic Reactions: Anaphylaxis
Drug Toxicity: Allergic Reactions
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Mechanism of Antibiotic Resistance in MRSA
Hypersensitivity Reactions: Cytolytic Reactions